US2012283203A1PendingUtilityA1

Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia

46
Assignee: NAIR MURALEEDHARAN GPriority: Jul 29, 2004Filed: Apr 30, 2012Published: Nov 8, 2012
Est. expiryJul 29, 2024(expired)· nominal 20-yr term from priority
A61P 5/10A61P 3/08A61P 3/06A61P 9/10A61P 3/10A61K 31/57A61K 31/7048A61P 3/04A61P 3/00A61K 31/353
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process of enhancing insulin excretion in a subject includes administering to the subject a polyphenol active ingredient. The polyphenol active ingredient is a purified cyanidin-3-glycoside alone or purified cyanidin alone. The pharmaceutically acceptable carrier is administered with the polyphenol active ingredient.

Claims

exact text as granted — not AI-modified
1 . A method for weight loss administering to a mammalian subject comprising a mixture of purified anthocyanins alone or in combination with purified anthocyanidins to induce weight loss in said subject. 
     
     
         2 . The method of  claim 1  wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins is cyanidin-3-glycoside alone. 
     
     
         3 . The process of  claim 1  wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins is cyanidin alone. 
     
     
         4 . The process of  claim 1  wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins is administered at a daily dosage of from 0.1 to 100 milligrams per kilogram of body weight of the subject. 
     
     
         5 . The process of  claim 1  wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins with administered with a pharmaceutically acceptable carrier, said wherein said mixture of purified anthocyanins alone or in combination with purified anthocyanidins and said pharmaceutically acceptable carrier both being essentially free of sugars.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.